ecrin-mdr-crcClinical1998CancerCancerInterventionalhttps://newmdr.ecrin.org/Study/2003063United States8Advanced adult primary liver cancerRecurrent colon cancerRecurrent endometrial carcinomaStage IV pancreatic cancerStage IV endometrial carcinomaFallopian tube cancerStage IV vulvar cancerRecurrent rectal cancerStage IV cervical cancerRecurrent breast cancerRecurrent uterine sarcomaRecurrent pancreatic cancerRecurrent vaginal cancerStage IV colon cancerMetastatic gastrointestinal carcinoid tumorUnresectable gallbladder cancerRecurrent vulvar cancerStage IV uterine sarcomaRecurrent cervical cancerStage IV gastric cancerRecurrent carcinoma of unknown primaryRecurrent ovarian epithelial cancerRecurrent gastrointestinal carcinoid tumorUnresectable extrahepatic bile duct cancerRecurrent extrahepatic bile duct cancerRecurrent esophageal cancerStage IV esophageal cancerStage IVB vaginal cancerStage IV rectal cancerRecurrent gestational trophoblastic tumorCarcinoma of the appendixRecurrent anal cancerStage IV anal cancerRecurrent gastric cancerStage IV breast cancerRecurrent adult primary liver cancerRecurrent gallbladder cancerRecurrent small intestine cancerStage IVA vaginal cancerStage IV ovarian epithelial cancerECRIN MDRCompletedfalseAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of aminocamptothecin in treating patients with advanced cancer of the peritoneal cavity.1998-08-152003063NCT00003548